HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2005
6001	6001 Harano M, Eto M, Iwai T, Tatsugami K, Kiyoshima K, et al. Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice CANCER RESEARCH. 2005 NOV 1; 65 (21): 10032-10040	4	8	20	39
6002	6002 Gittens JEI, Kidder GM Differential contributions of connexin37 and connexin43 to oogenesis revealed in chimeric reaggregated mouse ovaries JOURNAL OF CELL SCIENCE. 2005 NOV 1; 118 (21): 5071-5078	0	27	1	24
6003	6003 Minami E, Laflamme MA, Saffitz JE, Murry CE Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart CIRCULATION. 2005 NOV 8; 112 (19): 2951-2958	8	80	14	35
6004	6004 O'Neill TJ, Wamhoff BR, Owens GK, Skalak TC Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells CIRCULATION RESEARCH. 2005 NOV 11; 97 (10): 1027-1035	0	85	1	34
6005	6005 Mansoor W, Gilham DE, Thistlethwaite FC, Hawkins RE Engineering T cells for cancer therapy BRITISH JOURNAL OF CANCER. 2005 NOV 14; 93 (10): 1085-1091	0	18	5	62
6006	6006 Wu CJ, Krishnamurti L, Kutok JL, Biernacki M, Rogers S, et al. Evidence for ineffective erythropoiesis in severe sickle cell disease BLOOD. 2005 NOV 15; 106 (10): 3639-3645	8	18	11	43
6007	6007 Reyes M, Li S, Foraker J, Kimura E, Chamberlain JS Donor origin of multipotent adult progenitor cells in radiation chimeras BLOOD. 2005 NOV 15; 106 (10): 3646-3649	2	8	5	25
6008	6008 Noulin N, Quesniaux VFJ, Schnyder-Candrian S, Schnyder B, Maillet I, et al. Both hemopoietic and resident cells are required for MyD88-dependent pulmonary inflammatory response to inhaled endotoxin JOURNAL OF IMMUNOLOGY. 2005 NOV 15; 175 (10): 6861-6869	0	63	2	56
6009	6009 Kuwatani M, Ikarashi Y, Mineishi S, Asaka M, Wakasugi H An irradiation-free nonmyeloablative bone marrow transplantation model: Importance of the balance between donor T-cell number and the intensity of conditioning TRANSPLANTATION. 2005 NOV 15; 80 (9): 1145-1152	1	4	20	43
6010	6010 Mathes DW, Solari MG, Randolph MA, Gazelle GS, Yamada K, et al. Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow TRANSPLANTATION. 2005 NOV 15; 80 (9): 1300-1308	6	11	21	44
#	Date / Author / Journal	LCS	GCS	LCR	CR
6011	6011 Brown JR, Li SL, Kim H, Fisher DC, Cutler C, et al. High levels of early donor chimerism and treatment-responsive disease predict improved progression-free survival following non-myeloablative transplantation for advanced CLL. BLOOD. 2005 NOV 16; 106 (11): 166A-167A	0	1	0	0
6012	6012 Cho SG, Park MC, Min SY, Cho YG, Lee S, et al. Immunoregulatory effects of allogeneic mixed chimerism induced by T-cell depleted, nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity developed in interleukin-1 receptor antagonist-deficient mice. BLOOD. 2005 NOV 16; 106 (11): 372A-372A	0	0	0	0
6013	6013 Bai LJ, Deng YM, Dodds AJ, Milliken S, Moore J, et al. A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients BLOOD. 2005 NOV 16; 106 (11): 389B-389B	0	0	0	0
6014	6014 Armistead P, Mohseni M, Gerwin R, Zhang WD, Iravani M, et al. Post-transplant monitoring of erythroid lineage specific chimerism BLOOD. 2005 NOV 16; 106 (11): 392B-392B	0	0	0	0
6015	6015 Wang J, Zhou XT, Symons H, Levy MY, Fuchs EJ Effect of intravenous busulfan versus total body irradiation on donor chimerism and acute graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (AlloSCT) in mice BLOOD. 2005 NOV 16; 106 (11): 397B-397B	0	0	0	0
6016	6016 Cipkala D, McQuown K, Hendey L, Boyer M Role of Il-2, Il-7, and IL-15 in T cell mediated graft-vs-leukemia against human acute lymphoblastic leukemia in a NOD/scid chimeric mouse model BLOOD. 2005 NOV 16; 106 (11): 398B-398B	0	0	0	0
6017	6017 Buno I, Balsalobre P, Simon A, Iglesias G, Manzano C, et al. The different dynamics of chimerism evolution determines the success of myeloablative, reduced intensity conditioning and T-cell depleted allogeneic stem cell transplantation BLOOD. 2005 NOV 16; 106 (11): 406B-406B	0	0	0	0
6018	6018 Buno I, Balsalobre P, Simon A, Manzano C, Barroso D, et al. Mixed chimerism in T cells after allogeneic SCT allows early diagnosis of graft rejection and successful treatment with immunosuppression withdrawal and/or donor leukocyte infusion BLOOD. 2005 NOV 16; 106 (11): 407B-407B	0	0	0	0
6019	6019 Ai HS, Guo M, Yu CL, Wang DH, Qiao JH, et al. Reduced toxicity condition, mixed chimerism and donor stem cells infusion - A more effective and safely model of nonmyeloablative allogeneic stem cell transplantation (seventy-two cases report) BLOOD. 2005 NOV 16; 106 (11): 409B-409B	0	0	0	0
6020	6020 Chaddy M, Shanmugapriya S, Balasubramaniam P, SatheeshKumar S, Shaji RV, et al. Developing an algorithm for monitoring chimerism after allogeneic bone marrow transplantation - A single centre experience. BLOOD. 2005 NOV 16; 106 (11): 410B-410B	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
6021	6021 Shin MG, Kim HJ, Kim HR, Lee IK, Lee JJ, et al. Mitochondrial DNA microsatellites as new markers for the quantitative determination of hematopoietic chimerism after allogeneic stem cell transplantation. BLOOD. 2005 NOV 16; 106 (11): 410B-410B	0	0	0	0
6022	6022 Tabrizi R, Belloc F, Lafarge X, Perreau V, Bouabdallah K, et al. Dendritic cells recovery and chimerism after reduced intensity hematopoietic stem cell transplantation. BLOOD. 2005 NOV 16; 106 (11): 420B-420B	0	0	0	0
6023	6023 Tang XW, Wu DP, Sun AN Comparative study of chimerism dynamics between allogenic bone marrow transplantation and nonmyeloablative stem cell transplantation BLOOD. 2005 NOV 16; 106 (11): 436B-436B	0	0	0	0
6024	6024 Hardy NM, Fellowes V, Mariotti J, Carter C, June C, et al. Pilot clinical trial of adoptive immunotherapy with chimeric, co-stimulated tumor-infiltrating lymphocytes after allogeneic hematopoietic stem cell transplantation BLOOD. 2005 NOV 16; 106 (11): 438B-438B	0	0	0	0
6025	6025 Wang Y, Wu DP, Sun AN, Jin ZM, Qiu HY No significant benefit of marrow and blood HLA-haploidentical stem cell transplantations given by mothers with long-term fetomaternal microchimerism. BLOOD. 2005 NOV 16; 106 (11): 449B-450B	0	0	0	0
6026	6026 Tauro S, Lovell R, Begum G, McMullan DJ, Griffiths MJ, et al. Serial analysis of whole blood cell and CD3(+) T-lymphocyte chimerism following allogeneic stem cell transplantation with alemtuzumab containing reduced-intensity-conditioning (RIC). BLOOD. 2005 NOV 16; 106 (11): 505A-505A	0	0	0	0
6027	6027 Shaw BE, Byrne JL, Das-Gupta E, Carter I, Russell NH Converting mixed chimerism to full donor chimerism in recipients of campath-containing reduced intensity transplants reduces the relapse risk and results in significantly improved survival compared to those with persistent full donor chimerism BLOOD. 2005 NOV 16; 106 (11): 573A-573A	0	0	0	0
6028	6028 Kerbauy F, Fukuda T, Gooley T, Santos EB, Stempel H, et al. DLA-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning: The impact of donor lymphocyte infusion (DLI), pentostatin and graft composition on donor chimerism and rejection. BLOOD. 2005 NOV 16; 106 (11): 619A-620A	0	0	0	0
6029	6029 Kroeger N, Zagrivnaja M, Schwartz S, Badbaran A, Zabelina T, et al. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by real-time PCR and its value to quantify minimal residual disease in patients with multiple myeloma BLOOD. 2005 NOV 16; 106 (11): 771A-771A	0	0	0	0
6030	6030 Shimoni A, Luba T, Galina I, Hardan I, Shem-Tov N, et al. Persistent mixed chimerism in plasma cells following allogeneic stem-cell transplantation in patients with acute leukemia is a surrogate marker for leukemia relapse BLOOD. 2005 NOV 16; 106 (11): 771A-771A	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
6031	6031 Shaffer JM, Villard J, Means T, Dombkowski D, Dey B, et al. Fludarabine treatment is associated with depletion of host CD4+CD25(high), FOXP3+, CTLA-4+cells and increased Incidences of full donor chimerism and GVHD in non-myeloablative haploidentical hematopoietic cell transplant recipients BLOOD. 2005 NOV 16; 106 (11): 813A-813A	0	0	0	0
6032	6032 Khouri IF, Lee MS, Saliba RM, Acholonu SA, Valverde R, et al. Non-myeloablative allogeneic transplantation (NMT) with T-Cell replete graft for relapsed chemosensitive follicular lymphoma (FL): Donor lymphocyte infusion (DLI) to convert stable mixed chimerism to full donor chimerism is not necessary in the absence of disease progression. BLOOD. 2005 NOV 16; 106 (11): 1018A-1019A	0	0	0	0
6033	6033 Ting DT, Dey B, Chaudhary A, Colby C, Power K, et al. Development of late over early full donor chimerism (FDC) results in improved progression-free and overall survival in patients with advanced malignant lymphomas receiving nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT). BLOOD. 2005 NOV 16; 106 (11): 1020A-1020A	0	0	0	0
6034	6034 Masmas TN, Petersen SL, Madsen HO, Ryder L, Dickmeiss E, et al. Kinetics of early donor chimerism after nonmyeloablative haematopoietic stem cell transplantation monitored with high-resolution real time quantitative PCR. BLOOD. 2005 NOV 16; 106 (11): 1021A-1022A	0	0	0	0
6035	6035 Mohty M, Avinens O, Faucher C, Furst S, Blaise D, et al. Lymphoid chimerism (LC) kinetic after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT). BLOOD. 2005 NOV 16; 106 (11): 1023A-1024A	0	0	0	0
6036	6036 Panse JP, Storb R, Storer B, Santos EB, Wentzel C, et al. Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation TRANSPLANTATION. 2005 NOV 27; 80 (10): 1518-1521	3	4	7	22
6037	6037 Stalder AK, Ermini F, Bondolfi L, Krenger W, Burbach GJ, et al. Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice JOURNAL OF NEUROSCIENCE. 2005 NOV 30; 25 (48): 11125-11132	2	77	2	43
6038	6038 Kawahara T, Shimizu I, Ohdan H, Zhao G, Sykes M Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 2821-2829	10	15	7	44
6039	6039 Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, et al. Acute graft versus host disease after liver transplantation: Patterns of lymphocyte chimerism AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 2968-2973	0	32	11	29
6040	6040 Mengel M, Lehmann U, Kreipe H Chimerism after solid organ transplantation AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 3021-3021	0	1	5	5
#	Date / Author / Journal	LCS	GCS	LCR	CR
6041	6041 Koopmans M, Hovinga ICLK, de Heer E, Bruijn JA, Bajema IM Chimerism after solid organ transplantation: Not only numbers count AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 3022-3022	0	0	3	5
6042	6042 Carmirand G, Rousseau J, Ducharme ME, Rothstein DM, Tremblay JP Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. (vol 5, pg 1255, 2005) AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 3024-3024	0	0	0	1
6043	6043 Levasseur A, Navarro D, Punt PJ, Belaich JP, Asther M, et al. Construction of engineered bifunctional enzymes and their overproduction in Aspergillus niger for improved enzymatic tools to degrade agricultural by-products APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2005 DEC; 71 (12): 8132-8140	1	23	0	49
6044	6044 Smook MLF, Heeringa P, Damoiseaux JGMC, Daemen MJAP, de Winther MPJ, et al. Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosis ATHEROSCLEROSIS. 2005 DEC; 183 (2): 275-282	0	19	0	32
6045	6045 Nusair S, Or R, Junadi S, Amir G, Breuer R Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model CHEST. 2005 DEC; 128 (6): 4024-4029	3	4	10	21
6046	6046 Bapat SA, Mishra GC Stem cell pharmacogenomics: A reality check on stem cell therapy CURRENT OPINION IN MOLECULAR THERAPEUTICS. 2005 DEC; 7 (6): 551-556	0	1	3	36
6047	6047 Serikov VB, Popov BV, Kropotov AV, Tomilin NV BM-derived cells restore expression of peroxiredoxin V in the airways following acute naphthalene injury in mice CYTOTHERAPY. 2005 DEC; 7 (6): 483-493	0	1	3	32
6048	6048 Bottino R, Trucco M Multifaceted therapeutic approaches for a multigenic disease DIABETES. 2005 DEC; 54: S79-S86	1	10	4	92
6049	6049 Byskov AG, Faddy MJ, Lemmen JG, Andersen CY Eggs forever? DIFFERENTIATION. 2005 DEC; 73 (9-10): 438-446	0	53	1	67
6050	6050 Astigiano S, Damonte P, Fossati S, Boni L, Barbieri O Fate of embryonal carcinoma cells injected into postimplantation mouse embryos DIFFERENTIATION. 2005 DEC; 73 (9-10): 484-490	1	11	1	22
#	Date / Author / Journal	LCS	GCS	LCR	CR
6051	6051 Suckow MA, Zollman A, Cornelissen I, Casad M, Roahrig J, et al. Tissue distribution of fetal liver cells following in utero transplantation in mice EXPERIMENTAL BIOLOGY AND MEDICINE. 2005 DEC; 230 (11): 860-864	0	0	7	35
6052	6052 Ballen KK, Colvin G, Dey BR, Porter D, Westervelt P, et al. Cellular immune therapy for refractory cancers: novel therapeutic strategies EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1427-1435	0	5	28	54
6053	6053 Crcareva A, Saito T, Kunisato A, Kumano K, Suzuki T, et al. Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1459-1469	0	4	1	30
6054	6054 Martin FM, Bydlon G, Welsh ML, Friedman JS A method for rapid mouse siderocyte enrichment EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1493-1499	0	4	1	23
6055	6055 Schilling M, Besselmann M, Muller M, Strecker JK, Ringelstein EB, et al. Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: An investigation using green fluorescent protein transgenic bone marrow chimeric mice EXPERIMENTAL NEUROLOGY. 2005 DEC; 196 (2): 290-297	3	35	4	29
6056	6056 van den Boogaardt DEM, van Miert PPMC, Koekkoek KM, de Vaal YJH, van Rood JJ, et al. No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals HUMAN IMMUNOLOGY. 2005 DEC; 66 (12): 1203-1212	0	4	5	36
6057	6057 Ogawa Y, Kodama H, Kameyama K, Yamazaki K, Yasuoka H, et al. Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2005 DEC; 46 (12): 4519-4527	1	11	7	34
6058	6058 Hawkins T, Fuller J, Olson K, Speros S, Lernmark A DR.lyp/lyp bone marrow maintains lymphopenia and promotes diabetes in lyp/lyp but not in +/+ recipient DR.lyp BB rats JOURNAL OF AUTOIMMUNITY. 2005 DEC; 25 (4): 251-257	0	5	0	33
6059	6059 Stachel DK, Leipold A, Kuhlen M, Gravou-Apostolatou C, Hirv K, et al. Simultaneous control of third-degree graft-versus-host disease and prevention of recurrence of juvenile myelomonocytic leukemia (JMML) with 6-mercaptopurine following fulminant JMML relapse early after KIR mismatched bone marrow transplantation JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2005 DEC; 27 (12): 672-674	0	0	3	14
6060	6060 Streiffer R At the edge of humanity: Human stem cells, chimeras, and moral status KENNEDY INSTITUTE OF ETHICS JOURNAL. 2005 DEC; 15 (4): 347-370	5	28	5	53
#	Date / Author / Journal	LCS	GCS	LCR	CR
6061	6061 Patole PS, Schubert S, Hildinger K, Khandoga S, Khandoga A, et al. Toll-like receptor-4: Renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis KIDNEY INTERNATIONAL. 2005 DEC; 68 (6): 2582-2587	1	43	1	23
6062	6062 Schulenburg A, Fischer M, Kalhs P, Mitterbauer M, Rabitsch W, et al. Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation LEUKEMIA & LYMPHOMA. 2005 DEC; 46 (12): 1755-1760	2	9	3	15
6063	6063 Kanazawa T, Ogawa C, Taketani T, Taki T, Hayashi Y, et al. TLSI/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease LEUKEMIA & LYMPHOMA. 2005 DEC; 46 (12): 1833-1835	1	8	1	8
6064	6064 Flood VH, Johnson FL, Boshkov LK, Thomas GA, Nugent DJ, et al. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia PEDIATRIC BLOOD & CANCER. 2005 DEC; 45 (7): 971-975	0	9	3	31
6065	6065 Kletzel M, Jacobsohn D, Tse W, Duerst R Reduced intensity transplants (RIT) in pediatrics: A review PEDIATRIC TRANSPLANTATION. 2005 DEC; 9: 63-70	2	7	12	35
6066	6066 Sage D, Stanworth S, Turner D, Navarrete C Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis TRANSFUSION MEDICINE. 2005 DEC; 15 (6): 481-485	1	10	1	18
6067	6067 Bruno DA, Dhanireddy KK, Kirk AD Challenges in therapeutic strategies for transplantation: Where now from here? TRANSPLANT IMMUNOLOGY. 2005 DEC; 15 (2): 149-155	0	1	9	46
6068	6068 Galimberti S, Benedetti E, Morabito F, Fazzi R, Pacini S, et al. Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting TRANSPLANT IMMUNOLOGY. 2005 DEC; 15 (2): 173-177	2	2	8	20
6069	6069 Hajeer AH, Issa S, Alaskar A, Abdullah K, Awad M, et al. Neutrophils and lymphoid chimerism after adult living-related liver transplantation from a homozygous donor TRANSPLANTATION PROCEEDINGS. 2005 DEC; 37 (10): 4386-4388	1	1	6	11
6070	6070 Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, et al. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil TRANSPLANTATION PROCEEDINGS. 2005 DEC; 37 (10): 4579-4586	2	5	28	35
#	Date / Author / Journal	LCS	GCS	LCR	CR
6071	6071 Burroughs L, Mielcarek M, Little MT, Bridger G, MacFarland R, et al. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model BLOOD. 2005 DEC 1; 106 (12): 4002-4008	3	45	7	50
6072	6072 Millrain M, Scott D, Addey C, Dewchand H, Ellis P, et al. Identification of the immunodominant HYH2-D-k epitope and evaluation of the role of direct and indirect antigen presentation in HY responses JOURNAL OF IMMUNOLOGY. 2005 DEC 1; 175 (11): 7209-7217	1	13	1	57
6073	6073 Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells JOURNAL OF IMMUNOLOGY. 2005 DEC 1; 175 (11): 7661-7668	1	133	0	46
6074	6074 Moreno-Miralles I, Pan L, Keates-Baleeiro J, Durst-Goodwin K, Yang CY, et al. The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemia JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 DEC 2; 280 (48): 40097-40103	0	8	0	42
6075	6075 Giaccone L, McCune JS, Maris MB, Gooley TA, Sandmaier BM, et al. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation BLOOD. 2005 DEC 15; 106 (13): 4381-4388	6	39	8	40
6076	6076 Powell JD, Fitzhugh C, Kang EM, Hsieh M, Schwartz RH, et al. Low-dose radiation plus rapamycin promotes long-term bone marrow chimerism TRANSPLANTATION. 2005 DEC 15; 80 (11): 1541-1545	7	15	8	23
6077	6077 Basse G, Ribes D, Kamar N, Mehrenberger M, Esposito L, et al. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients TRANSPLANTATION. 2005 DEC 15; 80 (11): 1560-1564	2	43	1	19
6078	6078 Azuma M, Hirao A, Takubo K, Hamaguchi I, Kitamura T, et al. A quantitative matrigel assay for assessing repopulating capacity of prostate stem cells BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2005 DEC 16; 338 (2): 1164-1170	0	12	1	18
6079	6079 Muotri AR, Nakashima K, Toni N, Sandler VM, Gage FH Development of functional human embryonic stem cell-derived neurons in mouse brain PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 DEC 20; 102 (51): 18644-18648	5	76	1	36
6080	6080 Jain AB, Marcos A, Pokharna R, Shapiro R, Fontes PA, et al. Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: Long-term experience from a single center TRANSPLANTATION. 2005 DEC 27; 80 (12): 1692-1698	1	37	3	27
#	Date / Author / Journal	LCS	GCS	LCR	CR
6081	6081 Kiyomoto T, Ito T, Uchikoshi F, Ohkawa A, Akamaru Y, et al. The potent role of graft-derived NKR-P1(+)TCR alpha beta T+ (NKT) cells in the spontaneous acceptance of rat liver allografts TRANSPLANTATION. 2005 DEC 27; 80 (12): 1749-1755	1	8	7	32
6082	6082 Dor FJMF, Tseng YL, Kuwaki K, Gollackner B, Ramirez ML, et al. Immunological unresponsiveness in chimeric miniature swine following MHC-mismatched spleen transplantation TRANSPLANTATION. 2005 DEC 27; 80 (12): 1791-1804	3	11	26	55
2006
6083	6083 Duell T, Poleck-Dehlin B, Schmid C, Wunderlich B, Ledderose G, et al. Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia ACTA HAEMATOLOGICA. 2006; 116 (2): 131-136	0	5	2	39
6084	6084 Liu YS Historical and modern genetics of plant graft hybridization ADVANCES IN GENETICS. 2006; 56: 101-129	0	10	9	107
6085	6085 Trucco M Is facilitating pancreatic beta cell regeneration a valid option for clinical therapy? CELL TRANSPLANTATION. 2006; 15: S75-S84	0	8	8	49
6086	6086 Stephan L, Pichavant C, Bouchentouf M, Mills P, Camirand G, et al. Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use CELL TRANSPLANTATION. 2006; 15 (8-9): 835-846	1	7	15	61
6087	6087 George MP, Zhu XH, Stoner M, Duncan S A human-murine chimeric model of lung transplantation. CLINICAL IMMUNOLOGY. 2006; 119: S17-S17	0	0	0	0
6088	6088 Schoniger-Hekele M, Muller C, Kramer L, Dauber E, Mayr WR, et al. Graft versus host disease after orthotopic liver transplantation documented by analysis of short tandem repeat polymorphisms DIGESTION. 2006; 74 (3-4): 169-173	0	2	9	16
6089	6089 Yoshitsugu H, Nishimura M, Tateno C, Kataoka M, Takahash E, et al. Evaluation of human CYP1A2 and CYP3A4 mRNA expression in Hepatocytes from chimeric mice with humanized liver DRUG METABOLISM AND PHARMACOKINETICS. 2006; 21 (6): 465-474	3	9	1	26
6090	6090 Tan HP, Smaldone MC, Shapiro R Immunosuppressive preconditioning or induction regimens: Evidence to date DRUGS. 2006; 66 (12): 1535-1545	1	8	13	88
#	Date / Author / Journal	LCS	GCS	LCR	CR
6091	6091 Bhattacharya N Spontaneous transient rise of CD34 cells in peripheral blood after 72 hours in patients suffering from advanced malignancy with anemia: Effect and prognostic implications of treatment with placental umbilical cord whole blood transfusion EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 2006; 27 (3): 286-290	0	6	2	25
6092	6092 Saito T, Fujimoto T, Maegawa S, Inoue K, Tanaka M, et al. Visualization of primordial germ cells in vivo using GFP-nos1 3 ' UTR mRNA INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 2006; 50 (8): 691-700	7	28	5	40
6093	6093 Stevens AM Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? LUPUS. 2006; 15 (11): 820-826	4	12	16	66
6094	6094 Ishigaki H, Yamamoto Y, Ishida H, Kajino K, Itoh Y, et al. Preparation and functional analysis of tumor-infiltrating stroma cells using bone marrow chimera mice MICROBIOLOGY AND IMMUNOLOGY. 2006; 50 (8): 655-662	0	1	0	22
6095	6095 Quatra F, Lowenberg DW, Buncke HJ, Romeo OM, Brooks D, et al. Induction of tolerance to composite tissue allograft in a rat model MICROSURGERY. 2006; 26 (8): 573-578	1	3	12	32
6096	6096 Tonn T, Seifried E Natural killer cells for the treatment of malignancies TRANSFUSION MEDICINE AND HEMOTHERAPY. 2006; 33 (2): 144-149	0	2	4	50
6097	6097 Zander DS, Cogle CR, Theise ND, Crawford JM Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipient ANNALS OF CLINICAL AND LABORATORY SCIENCE. 2006 WIN; 36 (1): 47-52	0	12	6	26
6098	6098 Khariwala SS, Knott PD, Dan O, Klimczak A, Siemionow M, et al. Pulsed immunosuppression with everolimus and anti-alpha beta T-cell receptor: Laryngeal allograft preservation at six months ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY. 2006 JAN; 115 (1): 74-80	2	10	2	12
6099	6099 Di Terlizzi S, Zino E, Mazzi B, Magnani C, Tresoldi C, et al. Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2006 JAN; 12 (1): 95-101	0	9	5	33
6100	6100 Horwitz ME, Sullivan KM Chronic graft-versus-host disease BLOOD REVIEWS. 2006 JAN; 20 (1): 15-27	3	47	6	134

Date / Author / Journal

LCS

GCS

LCR

2005

6001

6001 Harano M, Eto M, Iwai T, Tatsugami K, Kiyoshima K, et al.

Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice

CANCER RESEARCH. 2005 NOV 1; 65 (21): 10032-10040

6002

6002 Gittens JEI, Kidder GM

Differential contributions of connexin37 and connexin43 to oogenesis revealed in chimeric reaggregated mouse ovaries

JOURNAL OF CELL SCIENCE. 2005 NOV 1; 118 (21): 5071-5078

6003

6003 Minami E, Laflamme MA, Saffitz JE, Murry CE

Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart

CIRCULATION. 2005 NOV 8; 112 (19): 2951-2958

6004

6004 O'Neill TJ, Wamhoff BR, Owens GK, Skalak TC

Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells

CIRCULATION RESEARCH. 2005 NOV 11; 97 (10): 1027-1035

6005

6005 Mansoor W, Gilham DE, Thistlethwaite FC, Hawkins RE

Engineering T cells for cancer therapy

BRITISH JOURNAL OF CANCER. 2005 NOV 14; 93 (10): 1085-1091

6006

6006 Wu CJ, Krishnamurti L, Kutok JL, Biernacki M, Rogers S, et al.

Evidence for ineffective erythropoiesis in severe sickle cell disease

BLOOD. 2005 NOV 15; 106 (10): 3639-3645

6007

6007 Reyes M, Li S, Foraker J, Kimura E, Chamberlain JS

Donor origin of multipotent adult progenitor cells in radiation chimeras

BLOOD. 2005 NOV 15; 106 (10): 3646-3649

6008

6008 Noulin N, Quesniaux VFJ, Schnyder-Candrian S, Schnyder B, Maillet I, et al.

Both hemopoietic and resident cells are required for MyD88-dependent pulmonary inflammatory response to inhaled endotoxin

JOURNAL OF IMMUNOLOGY. 2005 NOV 15; 175 (10): 6861-6869

6009

6009 Kuwatani M, Ikarashi Y, Mineishi S, Asaka M, Wakasugi H

An irradiation-free nonmyeloablative bone marrow transplantation model: Importance of the balance between donor T-cell number and the intensity of conditioning

TRANSPLANTATION. 2005 NOV 15; 80 (9): 1145-1152

6010

6010 Mathes DW, Solari MG, Randolph MA, Gazelle GS, Yamada K, et al.

Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow

TRANSPLANTATION. 2005 NOV 15; 80 (9): 1300-1308

Date / Author / Journal

LCS

GCS

LCR

6011

6011 Brown JR, Li SL, Kim H, Fisher DC, Cutler C, et al.

High levels of early donor chimerism and treatment-responsive disease predict improved progression-free survival following non-myeloablative transplantation for advanced CLL.

BLOOD. 2005 NOV 16; 106 (11): 166A-167A

6012

6012 Cho SG, Park MC, Min SY, Cho YG, Lee S, et al.BLOOD. 2005 NOV 16; 106 (11): 372A-372A

6013

6013 Bai LJ, Deng YM, Dodds AJ, Milliken S, Moore J, et al.

A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients

BLOOD. 2005 NOV 16; 106 (11): 389B-389B

6014

6014 Armistead P, Mohseni M, Gerwin R, Zhang WD, Iravani M, et al.

Post-transplant monitoring of erythroid lineage specific chimerism

BLOOD. 2005 NOV 16; 106 (11): 392B-392B

6015

6015 Wang J, Zhou XT, Symons H, Levy MY, Fuchs EJ

Effect of intravenous busulfan versus total body irradiation on donor chimerism and acute graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (AlloSCT) in mice

BLOOD. 2005 NOV 16; 106 (11): 397B-397B

6016

6016 Cipkala D, McQuown K, Hendey L, Boyer M

Role of Il-2, Il-7, and IL-15 in T cell mediated graft-vs-leukemia against human acute lymphoblastic leukemia in a NOD/scid chimeric mouse model

BLOOD. 2005 NOV 16; 106 (11): 398B-398B

6017

6017 Buno I, Balsalobre P, Simon A, Iglesias G, Manzano C, et al.

The different dynamics of chimerism evolution determines the success of myeloablative, reduced intensity conditioning and T-cell depleted allogeneic stem cell transplantation

BLOOD. 2005 NOV 16; 106 (11): 406B-406B

6018

6018 Buno I, Balsalobre P, Simon A, Manzano C, Barroso D, et al.

Mixed chimerism in T cells after allogeneic SCT allows early diagnosis of graft rejection and successful treatment with immunosuppression withdrawal and/or donor leukocyte infusion

BLOOD. 2005 NOV 16; 106 (11): 407B-407B

6019

6019 Ai HS, Guo M, Yu CL, Wang DH, Qiao JH, et al.

Reduced toxicity condition, mixed chimerism and donor stem cells infusion - A more effective and safely model of nonmyeloablative allogeneic stem cell transplantation (seventy-two cases report)

BLOOD. 2005 NOV 16; 106 (11): 409B-409B

6020

6020 Chaddy M, Shanmugapriya S, Balasubramaniam P, SatheeshKumar S, Shaji RV, et al.

Developing an algorithm for monitoring chimerism after allogeneic bone marrow transplantation - A single centre experience.

BLOOD. 2005 NOV 16; 106 (11): 410B-410B

Date / Author / Journal

LCS

GCS

LCR

6021

6021 Shin MG, Kim HJ, Kim HR, Lee IK, Lee JJ, et al.

Mitochondrial DNA microsatellites as new markers for the quantitative determination of hematopoietic chimerism after allogeneic stem cell transplantation.

BLOOD. 2005 NOV 16; 106 (11): 410B-410B

6022

6022 Tabrizi R, Belloc F, Lafarge X, Perreau V, Bouabdallah K, et al.

Dendritic cells recovery and chimerism after reduced intensity hematopoietic stem cell transplantation.

BLOOD. 2005 NOV 16; 106 (11): 420B-420B

6023

6023 Tang XW, Wu DP, Sun AN

Comparative study of chimerism dynamics between allogenic bone marrow transplantation and nonmyeloablative stem cell transplantation

BLOOD. 2005 NOV 16; 106 (11): 436B-436B

6024

6024 Hardy NM, Fellowes V, Mariotti J, Carter C, June C, et al.

Pilot clinical trial of adoptive immunotherapy with chimeric, co-stimulated tumor-infiltrating lymphocytes after allogeneic hematopoietic stem cell transplantation

BLOOD. 2005 NOV 16; 106 (11): 438B-438B

6025

6025 Wang Y, Wu DP, Sun AN, Jin ZM, Qiu HY

No significant benefit of marrow and blood HLA-haploidentical stem cell transplantations given by mothers with long-term fetomaternal microchimerism.

BLOOD. 2005 NOV 16; 106 (11): 449B-450B

6026

6026 Tauro S, Lovell R, Begum G, McMullan DJ, Griffiths MJ, et al.

Serial analysis of whole blood cell and CD3(+) T-lymphocyte chimerism following allogeneic stem cell transplantation with alemtuzumab containing reduced-intensity-conditioning (RIC).

BLOOD. 2005 NOV 16; 106 (11): 505A-505A

6027

6027 Shaw BE, Byrne JL, Das-Gupta E, Carter I, Russell NH

Converting mixed chimerism to full donor chimerism in recipients of campath-containing reduced intensity transplants reduces the relapse risk and results in significantly improved survival compared to those with persistent full donor chimerism

BLOOD. 2005 NOV 16; 106 (11): 573A-573A

6028

6028 Kerbauy F, Fukuda T, Gooley T, Santos EB, Stempel H, et al.

DLA-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning: The impact of donor lymphocyte infusion (DLI), pentostatin and graft composition on donor chimerism and rejection.

BLOOD. 2005 NOV 16; 106 (11): 619A-620A

6029

6029 Kroeger N, Zagrivnaja M, Schwartz S, Badbaran A, Zabelina T, et al.

Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by real-time PCR and its value to quantify minimal residual disease in patients with multiple myeloma

BLOOD. 2005 NOV 16; 106 (11): 771A-771A

6030

6030 Shimoni A, Luba T, Galina I, Hardan I, Shem-Tov N, et al.

Persistent mixed chimerism in plasma cells following allogeneic stem-cell transplantation in patients with acute leukemia is a surrogate marker for leukemia relapse

BLOOD. 2005 NOV 16; 106 (11): 771A-771A

Date / Author / Journal

LCS

GCS

LCR

6031

6031 Shaffer JM, Villard J, Means T, Dombkowski D, Dey B, et al.

Fludarabine treatment is associated with depletion of host CD4+CD25(high), FOXP3+, CTLA-4+cells and increased Incidences of full donor chimerism and GVHD in non-myeloablative haploidentical hematopoietic cell transplant recipients

BLOOD. 2005 NOV 16; 106 (11): 813A-813A

6032

6032 Khouri IF, Lee MS, Saliba RM, Acholonu SA, Valverde R, et al.

Non-myeloablative allogeneic transplantation (NMT) with T-Cell replete graft for relapsed chemosensitive follicular lymphoma (FL): Donor lymphocyte infusion (DLI) to convert stable mixed chimerism to full donor chimerism is not necessary in the absence of disease progression.

BLOOD. 2005 NOV 16; 106 (11): 1018A-1019A

6033

6033 Ting DT, Dey B, Chaudhary A, Colby C, Power K, et al.

Development of late over early full donor chimerism (FDC) results in improved progression-free and overall survival in patients with advanced malignant lymphomas receiving nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT).

BLOOD. 2005 NOV 16; 106 (11): 1020A-1020A

6034

6034 Masmas TN, Petersen SL, Madsen HO, Ryder L, Dickmeiss E, et al.

Kinetics of early donor chimerism after nonmyeloablative haematopoietic stem cell transplantation monitored with high-resolution real time quantitative PCR.

BLOOD. 2005 NOV 16; 106 (11): 1021A-1022A

6035

6035 Mohty M, Avinens O, Faucher C, Furst S, Blaise D, et al.

Lymphoid chimerism (LC) kinetic after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT).

BLOOD. 2005 NOV 16; 106 (11): 1023A-1024A

6036

6036 Panse JP, Storb R, Storer B, Santos EB, Wentzel C, et al.

Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation

TRANSPLANTATION. 2005 NOV 27; 80 (10): 1518-1521

6037

6037 Stalder AK, Ermini F, Bondolfi L, Krenger W, Burbach GJ, et al.

Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice

JOURNAL OF NEUROSCIENCE. 2005 NOV 30; 25 (48): 11125-11132

6038

6038 Kawahara T, Shimizu I, Ohdan H, Zhao G, Sykes M

Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism

AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 2821-2829

6039

6039 Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, et al.

Acute graft versus host disease after liver transplantation: Patterns of lymphocyte chimerism

AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 2968-2973

6040

6040 Mengel M, Lehmann U, Kreipe H

Chimerism after solid organ transplantation

AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 3021-3021

Date / Author / Journal

LCS

GCS

LCR

6041

6041 Koopmans M, Hovinga ICLK, de Heer E, Bruijn JA, Bajema IM

Chimerism after solid organ transplantation: Not only numbers count

AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 3022-3022

6042

6042 Carmirand G, Rousseau J, Ducharme ME, Rothstein DM, Tremblay JP

Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. (vol 5, pg 1255, 2005)

AMERICAN JOURNAL OF TRANSPLANTATION. 2005 DEC; 5 (12): 3024-3024

6043

6043 Levasseur A, Navarro D, Punt PJ, Belaich JP, Asther M, et al.

Construction of engineered bifunctional enzymes and their overproduction in Aspergillus niger for improved enzymatic tools to degrade agricultural by-products

APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2005 DEC; 71 (12): 8132-8140

6044

6044 Smook MLF, Heeringa P, Damoiseaux JGMC, Daemen MJAP, de Winther MPJ, et al.

Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosis

ATHEROSCLEROSIS. 2005 DEC; 183 (2): 275-282

6045

6045 Nusair S, Or R, Junadi S, Amir G, Breuer R

Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model

CHEST. 2005 DEC; 128 (6): 4024-4029

6046

6046 Bapat SA, Mishra GC

Stem cell pharmacogenomics: A reality check on stem cell therapy

CURRENT OPINION IN MOLECULAR THERAPEUTICS. 2005 DEC; 7 (6): 551-556

6047

6047 Serikov VB, Popov BV, Kropotov AV, Tomilin NV

BM-derived cells restore expression of peroxiredoxin V in the airways following acute naphthalene injury in mice

CYTOTHERAPY. 2005 DEC; 7 (6): 483-493

6048

6048 Bottino R, Trucco M

Multifaceted therapeutic approaches for a multigenic disease

DIABETES. 2005 DEC; 54: S79-S86

6049

6049 Byskov AG, Faddy MJ, Lemmen JG, Andersen CY

Eggs forever?

DIFFERENTIATION. 2005 DEC; 73 (9-10): 438-446

6050

6050 Astigiano S, Damonte P, Fossati S, Boni L, Barbieri O

Fate of embryonal carcinoma cells injected into postimplantation mouse embryos

DIFFERENTIATION. 2005 DEC; 73 (9-10): 484-490

Date / Author / Journal

LCS

GCS

LCR

6051

6051 Suckow MA, Zollman A, Cornelissen I, Casad M, Roahrig J, et al.

Tissue distribution of fetal liver cells following in utero transplantation in mice

EXPERIMENTAL BIOLOGY AND MEDICINE. 2005 DEC; 230 (11): 860-864

6052

6052 Ballen KK, Colvin G, Dey BR, Porter D, Westervelt P, et al.

Cellular immune therapy for refractory cancers: novel therapeutic strategies

EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1427-1435

6053

6053 Crcareva A, Saito T, Kunisato A, Kumano K, Suzuki T, et al.

Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery

EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1459-1469

6054

6054 Martin FM, Bydlon G, Welsh ML, Friedman JS

A method for rapid mouse siderocyte enrichment

EXPERIMENTAL HEMATOLOGY. 2005 DEC; 33 (12): 1493-1499

6055

6055 Schilling M, Besselmann M, Muller M, Strecker JK, Ringelstein EB, et al.EXPERIMENTAL NEUROLOGY. 2005 DEC; 196 (2): 290-297

6056

6056 van den Boogaardt DEM, van Miert PPMC, Koekkoek KM, de Vaal YJH, van Rood JJ, et al.

No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals

HUMAN IMMUNOLOGY. 2005 DEC; 66 (12): 1203-1212

6057

6057 Ogawa Y, Kodama H, Kameyama K, Yamazaki K, Yasuoka H, et al.

Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2005 DEC; 46 (12): 4519-4527

6058

6058 Hawkins T, Fuller J, Olson K, Speros S, Lernmark A

DR.lyp/lyp bone marrow maintains lymphopenia and promotes diabetes in lyp/lyp but not in +/+ recipient DR.lyp BB rats

JOURNAL OF AUTOIMMUNITY. 2005 DEC; 25 (4): 251-257

6059

6059 Stachel DK, Leipold A, Kuhlen M, Gravou-Apostolatou C, Hirv K, et al.JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2005 DEC; 27 (12): 672-674

6060

6060 Streiffer R

At the edge of humanity: Human stem cells, chimeras, and moral status

KENNEDY INSTITUTE OF ETHICS JOURNAL. 2005 DEC; 15 (4): 347-370

Date / Author / Journal

LCS

GCS

LCR

6061

6061 Patole PS, Schubert S, Hildinger K, Khandoga S, Khandoga A, et al.

Toll-like receptor-4: Renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis

KIDNEY INTERNATIONAL. 2005 DEC; 68 (6): 2582-2587

6062

6062 Schulenburg A, Fischer M, Kalhs P, Mitterbauer M, Rabitsch W, et al.

Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation

LEUKEMIA & LYMPHOMA. 2005 DEC; 46 (12): 1755-1760

6063

6063 Kanazawa T, Ogawa C, Taketani T, Taki T, Hayashi Y, et al.

TLSI/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease

LEUKEMIA & LYMPHOMA. 2005 DEC; 46 (12): 1833-1835

6064

6064 Flood VH, Johnson FL, Boshkov LK, Thomas GA, Nugent DJ, et al.

Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia

PEDIATRIC BLOOD & CANCER. 2005 DEC; 45 (7): 971-975

6065

6065 Kletzel M, Jacobsohn D, Tse W, Duerst R

Reduced intensity transplants (RIT) in pediatrics: A review

PEDIATRIC TRANSPLANTATION. 2005 DEC; 9: 63-70

6066

6066 Sage D, Stanworth S, Turner D, Navarrete C

Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis

TRANSFUSION MEDICINE. 2005 DEC; 15 (6): 481-485

6067

6067 Bruno DA, Dhanireddy KK, Kirk AD

Challenges in therapeutic strategies for transplantation: Where now from here?

TRANSPLANT IMMUNOLOGY. 2005 DEC; 15 (2): 149-155

6068

6068 Galimberti S, Benedetti E, Morabito F, Fazzi R, Pacini S, et al.

Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting

TRANSPLANT IMMUNOLOGY. 2005 DEC; 15 (2): 173-177

6069

6069 Hajeer AH, Issa S, Alaskar A, Abdullah K, Awad M, et al.

Neutrophils and lymphoid chimerism after adult living-related liver transplantation from a homozygous donor

TRANSPLANTATION PROCEEDINGS. 2005 DEC; 37 (10): 4386-4388

6070

6070 Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, et al.

Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil

TRANSPLANTATION PROCEEDINGS. 2005 DEC; 37 (10): 4579-4586

Date / Author / Journal

LCS

GCS

LCR

6071

6071 Burroughs L, Mielcarek M, Little MT, Bridger G, MacFarland R, et al.

Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model

BLOOD. 2005 DEC 1; 106 (12): 4002-4008

6072

6072 Millrain M, Scott D, Addey C, Dewchand H, Ellis P, et al.

Identification of the immunodominant HYH2-D-k epitope and evaluation of the role of direct and indirect antigen presentation in HY responses

JOURNAL OF IMMUNOLOGY. 2005 DEC 1; 175 (11): 7209-7217

6073

6073 Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, et al.

Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells

JOURNAL OF IMMUNOLOGY. 2005 DEC 1; 175 (11): 7661-7668

133

6074

6074 Moreno-Miralles I, Pan L, Keates-Baleeiro J, Durst-Goodwin K, Yang CY, et al.

The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemia

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 DEC 2; 280 (48): 40097-40103

6075

6075 Giaccone L, McCune JS, Maris MB, Gooley TA, Sandmaier BM, et al.

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

BLOOD. 2005 DEC 15; 106 (13): 4381-4388

6076

6076 Powell JD, Fitzhugh C, Kang EM, Hsieh M, Schwartz RH, et al.

Low-dose radiation plus rapamycin promotes long-term bone marrow chimerism

TRANSPLANTATION. 2005 DEC 15; 80 (11): 1541-1545

6077

6077 Basse G, Ribes D, Kamar N, Mehrenberger M, Esposito L, et al.

Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients

TRANSPLANTATION. 2005 DEC 15; 80 (11): 1560-1564

6078

6078 Azuma M, Hirao A, Takubo K, Hamaguchi I, Kitamura T, et al.

A quantitative matrigel assay for assessing repopulating capacity of prostate stem cells

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2005 DEC 16; 338 (2): 1164-1170

6079

6079 Muotri AR, Nakashima K, Toni N, Sandler VM, Gage FH

Development of functional human embryonic stem cell-derived neurons in mouse brain

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 DEC 20; 102 (51): 18644-18648

6080

6080 Jain AB, Marcos A, Pokharna R, Shapiro R, Fontes PA, et al.

Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: Long-term experience from a single center

TRANSPLANTATION. 2005 DEC 27; 80 (12): 1692-1698

Date / Author / Journal

LCS

GCS

LCR

6081

6081 Kiyomoto T, Ito T, Uchikoshi F, Ohkawa A, Akamaru Y, et al.

The potent role of graft-derived NKR-P1(+)TCR alpha beta T+ (NKT) cells in the spontaneous acceptance of rat liver allografts

TRANSPLANTATION. 2005 DEC 27; 80 (12): 1749-1755

6082

6082 Dor FJMF, Tseng YL, Kuwaki K, Gollackner B, Ramirez ML, et al.

Immunological unresponsiveness in chimeric miniature swine following MHC-mismatched spleen transplantation

TRANSPLANTATION. 2005 DEC 27; 80 (12): 1791-1804

2006

6083

6083 Duell T, Poleck-Dehlin B, Schmid C, Wunderlich B, Ledderose G, et al.

Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia

ACTA HAEMATOLOGICA. 2006; 116 (2): 131-136

6084

6084 Liu YS

Historical and modern genetics of plant graft hybridization

ADVANCES IN GENETICS. 2006; 56: 101-129

107

6085

6085 Trucco M

Is facilitating pancreatic beta cell regeneration a valid option for clinical therapy?

CELL TRANSPLANTATION. 2006; 15: S75-S84

6086

6086 Stephan L, Pichavant C, Bouchentouf M, Mills P, Camirand G, et al.

Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use

CELL TRANSPLANTATION. 2006; 15 (8-9): 835-846

6087

6087 George MP, Zhu XH, Stoner M, Duncan S

A human-murine chimeric model of lung transplantation.

CLINICAL IMMUNOLOGY. 2006; 119: S17-S17

6088

6088 Schoniger-Hekele M, Muller C, Kramer L, Dauber E, Mayr WR, et al.

Graft versus host disease after orthotopic liver transplantation documented by analysis of short tandem repeat polymorphisms

DIGESTION. 2006; 74 (3-4): 169-173

6089

6089 Yoshitsugu H, Nishimura M, Tateno C, Kataoka M, Takahash E, et al.

Evaluation of human CYP1A2 and CYP3A4 mRNA expression in Hepatocytes from chimeric mice with humanized liver

DRUG METABOLISM AND PHARMACOKINETICS. 2006; 21 (6): 465-474

6090

6090 Tan HP, Smaldone MC, Shapiro R

Immunosuppressive preconditioning or induction regimens: Evidence to date

DRUGS. 2006; 66 (12): 1535-1545

Date / Author / Journal

6091

Spontaneous transient rise of CD34 cells in peripheral blood after 72 hours in patients suffering from advanced malignancy with anemia: Effect and prognostic implications of treatment with placental umbilical cord whole blood transfusion

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 2006; 27 (3): 286-290

6092

6092 Saito T, Fujimoto T, Maegawa S, Inoue K, Tanaka M, et al.

Visualization of primordial germ cells in vivo using GFP-nos1 3 ' UTR mRNA

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 2006; 50 (8): 691-700

6093

6093 Stevens AM

Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders?

LUPUS. 2006; 15 (11): 820-826

6094

6094 Ishigaki H, Yamamoto Y, Ishida H, Kajino K, Itoh Y, et al.

Preparation and functional analysis of tumor-infiltrating stroma cells using bone marrow chimera mice

MICROBIOLOGY AND IMMUNOLOGY. 2006; 50 (8): 655-662

6095

6095 Quatra F, Lowenberg DW, Buncke HJ, Romeo OM, Brooks D, et al.

Induction of tolerance to composite tissue allograft in a rat model

MICROSURGERY. 2006; 26 (8): 573-578

6096

6096 Tonn T, Seifried E

Natural killer cells for the treatment of malignancies

TRANSFUSION MEDICINE AND HEMOTHERAPY. 2006; 33 (2): 144-149

6097

6097 Zander DS, Cogle CR, Theise ND, Crawford JM

Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipient

ANNALS OF CLINICAL AND LABORATORY SCIENCE. 2006 WIN; 36 (1): 47-52

6098

6098 Khariwala SS, Knott PD, Dan O, Klimczak A, Siemionow M, et al.

Pulsed immunosuppression with everolimus and anti-alpha beta T-cell receptor: Laryngeal allograft preservation at six months

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY. 2006 JAN; 115 (1): 74-80

6099

6099 Di Terlizzi S, Zino E, Mazzi B, Magnani C, Tresoldi C, et al.

Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2006 JAN; 12 (1): 95-101

6100

6100 Horwitz ME, Sullivan KM

Chronic graft-versus-host disease

BLOOD REVIEWS. 2006 JAN; 20 (1): 15-27

134

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records